CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells
- 12 July 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (31) , 4258-4269
- https://doi.org/10.1038/sj.onc.1204559
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 35 references indexed in Scilit:
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- The Putative Apoptosis Inhibitor IEX-1L Is a Mutant Nonspliced Variant of p22PRG1/IEX-1 and Is Not Expressed in VivoBiochemical and Biophysical Research Communications, 1999
- Protein Kinase Cι Activity Is Necessary for Bcr-Abl-mediated Resistance to Drug-induced ApoptosisJournal of Biological Chemistry, 1999
- The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFκBFEBS Letters, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- Fas activates NF-κB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-αCell Death & Differentiation, 1997
- Apoptosis by Death FactorCell, 1997
- Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymesFEBS Letters, 1996
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996